venlafaxine hydrochloride has been researched along with Chronic Illness in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (15.63) | 18.2507 |
| 2000's | 13 (40.63) | 29.6817 |
| 2010's | 14 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattingh, CJ; Ipser, JC; Kariuki, CM; Stein, DJ; Tromp, SA; van Balkom, AJ; Williams, T | 1 |
| Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S | 1 |
| Bombardier, CH; Brooks, L; Fann, JR; Heinemann, AW; McCullumsmith, CB; Richards, JS; Tate, DG; Temkin, NR; Warms, C; Warren, AM; Wilson, CS | 1 |
| Bhikoo, R; Botha, VE; Merriman, M | 1 |
| Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, G; Iyengar, S; Keller, M; Kennard, B; Leonard, H; Mayes, T; McCracken, J; Porta, G; Ritz, L; Ryan, N; Shamseddeen, W; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD | 1 |
| Begré, S; Gerber, M; Traber, M; von Känel, R | 2 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| Batysheva, TT; Boĭko, AN; Guseva, ME; Kamchatnov, PR; Kostenko, EV; Nesterova, OS; Otcheskaia, OV; Zaĭtsev, KA; Zhuravleva, EIu | 1 |
| Garg, R; Gaur, V; Kumar, A; Kumar, P | 1 |
| Bitter, I; Karamustafalioglu, O; Koponen, H; Mohr, P; Sartorius, N; Seifritz, E; Svestka, J | 1 |
| Amr, YM; Yousef, AA | 1 |
| Liu, X; Mullins, CD; Wang, J | 1 |
| Du, G; Gao, X; Guo, X; Li, Z; Qin, X; Sun, H; Zhang, L; Zheng, X; Zhou, Y | 1 |
| Barak, Y; Baruch, Y; Swartz, M | 1 |
| Cui, J; Du, GH; Gao, XX; Li, ZF; Li, ZY; Liu, XJ; Qin, XM; Sun, HF; Zhang, LZ; Zhou, YZ | 1 |
| Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Fava, M; Haley, CL; Kurian, BT; Morris, DW; Nierenberg, AA; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Bo-Hua, Z; He, L; Hong-Ju, Y; Jun-Wei, W; Nan, Z; Wei-Guo, S; Wei-Xiu, Y; Zhe-Hui, G; Zheng-Hua, G; Zhi-Pu, L; Zhong-Wei, J | 1 |
| Karp, JF | 1 |
| Delgado, PL | 1 |
| Briley, M | 1 |
| Andersen, OK; Arendt-Nielsen, L; Disci, R; Kiziltan, E; Koknel Talu, G; Ozyalcin, S; Yucel, A; Yucel, B | 1 |
| Lang, AE; Voon, V | 1 |
| Chen, Z; Dyck, L; Haimanot, S; He, J; Li, X; Li, XM; Xu, H | 1 |
| Fotiou, F; Fountoulakis, KN; Gerasimou, G; Grammatikos, P; Iacovides, A; Kaprinis, G; Karamouzis, M | 1 |
| Schulte, H; Songer, DA | 1 |
| Rowbotham, MC; Taylor, K | 1 |
| Andersson, G; Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hindfelt, B; Wikell, C | 1 |
| Emamian, ES; Fatemi, SH; Kist, DA | 1 |
| Poirier, MF | 1 |
| Allgulander, C; Hackett, D; Salinas, E | 1 |
3 review(s) available for venlafaxine hydrochloride and Chronic Illness
| Article | Year |
|---|---|
Pharmacotherapy for social anxiety disorder (SAnD).
Topics: Adult; Aged; Anticonvulsants; Chronic Disease; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Phobia, Social; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult | 2017 |
Common pathways of depression and pain.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Norepinephrine; Pain; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Clinical experience with dual action antidepressants in different chronic pain syndromes.
Topics: Antidepressive Agents; Chronic Disease; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride | 2004 |
11 trial(s) available for venlafaxine hydrochloride and Chronic Illness
| Article | Year |
|---|---|
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial.
Topics: Adolescent; Adult; Chronic Disease; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Spinal Cord Injuries; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Personality Inventory; Prognosis; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.
Topics: Acute Disease; Adult; Amines; Analgesics; Breast Neoplasms; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Mastectomy, Radical; Mastectomy, Segmental; Middle Aged; Morphine; Pain Measurement; Pain, Postoperative; Perioperative Care; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
Topics: Adult; Aged; Analgesics; Chronic Disease; Cyclohexanols; Double-Blind Method; Electric Stimulation; Female; Hot Temperature; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Pain Measurement; Pain Threshold; Pain, Intractable; Peripheral Nervous System Diseases; Physical Stimulation; Placebos; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Antidepressant treatment outcomes of psychogenic movement disorder.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Chronic Disease; Citalopram; Combined Modality Therapy; Comorbidity; Conversion Disorder; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hypochondriasis; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Venlafaxine hydrochloride and chronic pain.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1996 |
[The concept of resistant depression and therapeutic strategies, particularly, with venlafaxine].
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Humans; Paroxetine; Remission, Spontaneous; Severity of Illness Index; Venlafaxine Hydrochloride | 1999 |
Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chronic Disease; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2001 |
18 other study(ies) available for venlafaxine hydrochloride and Chronic Illness
| Article | Year |
|---|---|
Venlafaxine-induced intraocular pressure rise in a patient with open angle glaucoma.
Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Brimonidine Tartrate; Chronic Disease; Depressive Disorder; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Tonometry, Ocular; Venlafaxine Hydrochloride | 2016 |
Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine.
Topics: Acculturation; Adult; Analgesics; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Culture; Cyclohexanols; Depression; Ethnicity; Europe; Europe, Eastern; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Physicians, Family; Psychophysiologic Disorders; Severity of Illness Index; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
[Results of a study of velaxin (venlafaxine) efficacy in patients with subacute and chronic spondylogenic dorsalgia].
Topics: Adult; Analgesics; Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Patient Selection; Radiography; Selective Serotonin Reuptake Inhibitors; Spinal Diseases; Spinal Osteophytosis; Spondylitis; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Caffeine; Central Nervous System Stimulants; Chronic Disease; Cyclohexanols; Depressive Disorder; Disease Models, Animal; Enzyme Inhibitors; Male; Methylene Blue; Mice; Mice, Inbred Strains; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Random Allocation; Swimming; Venlafaxine Hydrochloride | 2010 |
Management of depression in the presence of pain symptoms.
Topics: Antidepressive Agents; Brain; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Mind-Body Relations, Metaphysical; Norepinephrine; Pain; Psychotherapy; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
Topics: Adolescent; Adult; Algorithms; Antidepressive Agents; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dosage Forms; Duloxetine Hydrochloride; Female; Humans; Male; Medication Adherence; Middle Aged; Pain; Retrospective Studies; Somatoform Disorders; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2011 |
Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Body Weight; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Food Preferences; Gas Chromatography-Mass Spectrometry; Male; Metabolomics; Motor Activity; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: a retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Inpatients; Israel; Male; Medical Records Systems, Computerized; Middle Aged; Psychiatric Status Rating Scales; Receptors, Adrenergic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Fluoxetine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Motor Activity; Multivariate Analysis; Rats; Rats, Sprague-Dawley; Stress, Psychological; Sucrose; Venlafaxine Hydrochloride | 2012 |
Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury.
Topics: Amines; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Memantine; Pain; Pain Threshold; Pregabalin; Prodrugs; Rats; Sciatic Neuropathy; Structure-Activity Relationship; Venlafaxine Hydrochloride | 2004 |
Venlafaxine XR and chronic pelvic pain syndrome.
Topics: Adult; Chronic Disease; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Male; Pelvic Pain; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Proliferation; Chronic Disease; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hippocampus; Neuronal Plasticity; Neurons; Quetiapine Fumarate; Rats; Restraint, Physical; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Stem Cells; Stress, Psychological; Venlafaxine Hydrochloride | 2006 |
Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods?
Topics: Adult; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Dexamethasone; Dexfenfluramine; Dominance, Cerebral; Electrooculography; Electroretinography; Evoked Potentials, Visual; Female; Follow-Up Studies; Globus Pallidus; Humans; Hydrocortisone; Male; Middle Aged; Prognosis; Prolactin; Recurrence; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Primary Health Care; Somatoform Disorders; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Venlafaxine for the treatment of chronic pain.
Topics: Adult; Antidepressive Agents, Second-Generation; Back Pain; Chronic Disease; Cyclohexanols; Depressive Disorder; Female; Humans; Pain; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Chronic Disease; Citalopram; Cyclohexanols; Hepatic Encephalopathy; Locomotion; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 1999 |
Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chronic Disease; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Psychiatric Status Rating Scales; Recurrence; Venlafaxine Hydrochloride | 1999 |